According to this latest study, the 2021 growth of Non-invasive Neuromodulation Device will have significant change from previous year. By the most conservative estimates of global Non-invasive Neuromodulation Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Non-invasive Neuromodulation Device market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Neuromodulation Device market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Transcranial Direct Current Stimulation (tDCS)

Transcranial Alternating Current Stimulation (tACS)

Transcranial Pulsed Current Stimulation (tPCS)

Transcranial Random Noise Stimulation (tRNS)

Electroconvulsive therapy (ECT)

Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Hospital

Clinic

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Neuroelectrics

Magstim

NeuroCare Group

Soterix Medical

Newronika

Rogue Resolutions

Medtronic

Philips Healthcare

Shenzhen Yingchi Technology

Shenzhen Hanix United

Shanghai Qiankang Medical Care Company

TCT Research

EB Neuro SpA

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Non-invasive Neuromodulation Device Consumption 2016-2026

2.1.2 Non-invasive Neuromodulation Device Consumption CAGR by Region

2.2 Non-invasive Neuromodulation Device Segment by Type

2.2.1 Transcranial Direct Current Stimulation (tDCS)

2.2.2 Transcranial Alternating Current Stimulation (tACS)

2.2.3 Transcranial Pulsed Current Stimulation (tPCS)

2.2.4 Transcranial Random Noise Stimulation (tRNS)

2.2.5 Electroconvulsive therapy (ECT)

2.2.6 Others

2.3 Non-invasive Neuromodulation Device Sales by Type

2.3.1 Global Non-invasive Neuromodulation Device Sales Market Share by Type (2016-2021)

2.3.2 Global Non-invasive Neuromodulation Device Revenue and Market Share by Type (2016-2021)

2.3.3 Global Non-invasive Neuromodulation Device Sale Price by Type (2016-2021)

2.4 Non-invasive Neuromodulation Device Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Non-invasive Neuromodulation Device Sales by Application

2.5.1 Global Non-invasive Neuromodulation Device Sale Market Share by Application (2016-2021)

2.5.2 Global Non-invasive Neuromodulation Device Revenue and Market Share by Application (2016-2021)

2.5.3 Global Non-invasive Neuromodulation Device Sale Price by Application (2016-2021)

3 Global Non-invasive Neuromodulation Device by Company

3.1 Global Non-invasive Neuromodulation Device Sales Market Share by Company

3.1.1 Global Non-invasive Neuromodulation Device Sales by Company (2019-2021)

3.1.2 Global Non-invasive Neuromodulation Device Sales Market Share by Company (2019-2021)

3.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Company

3.2.1 Global Non-invasive Neuromodulation Device Revenue by Company (2019-2021)

3.2.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Company (2019-2021)

3.3 Global Non-invasive Neuromodulation Device Sale Price by Company

3.4 Global Manufacturers Non-invasive Neuromodulation Device Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Non-invasive Neuromodulation Device Product Location Distribution

3.4.2 Players Non-invasive Neuromodulation Device Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Non-invasive Neuromodulation Device by Region

4.1 Global Non-invasive Neuromodulation Device by Region

4.1.1 Global Non-invasive Neuromodulation Device Sales by Region

4.1.2 Global Non-invasive Neuromodulation Device Revenue by Region

4.2 Americas Non-invasive Neuromodulation Device Sales Growth

4.3 APAC Non-invasive Neuromodulation Device Sales Growth

4.4 Europe Non-invasive Neuromodulation Device Sales Growth

4.5 Middle East & Africa Non-invasive Neuromodulation Device Sales Growth

5 Americas

5.1 Americas Non-invasive Neuromodulation Device Sales by Country

5.1.1 Americas Non-invasive Neuromodulation Device Sales by Country (2016-2021)

5.1.2 Americas Non-invasive Neuromodulation Device Revenue by Country (2016-2021)

5.2 Americas Non-invasive Neuromodulation Device Sales by Type

5.3 Americas Non-invasive Neuromodulation Device Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Non-invasive Neuromodulation Device Sales by Region

6.1.1 APAC Non-invasive Neuromodulation Device Sales by Region (2016-2021)

6.1.2 APAC Non-invasive Neuromodulation Device Revenue by Region (2016-2021)

6.2 APAC Non-invasive Neuromodulation Device Sales by Type

6.3 APAC Non-invasive Neuromodulation Device Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Non-invasive Neuromodulation Device by Country

7.1.1 Europe Non-invasive Neuromodulation Device Sales by Country (2016-2021)

7.1.2 Europe Non-invasive Neuromodulation Device Revenue by Country (2016-2021)

7.2 Europe Non-invasive Neuromodulation Device Sales by Type

7.3 Europe Non-invasive Neuromodulation Device Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Non-invasive Neuromodulation Device by Country

8.1.1 Middle East & Africa Non-invasive Neuromodulation Device Sales by Country (2016-2021)

8.1.2 Middle East & Africa Non-invasive Neuromodulation Device Revenue by Country (2016-2021)

8.2 Middle East & Africa Non-invasive Neuromodulation Device Sales by Type

8.3 Middle East & Africa Non-invasive Neuromodulation Device Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Non-invasive Neuromodulation Device Distributors

10.3 Non-invasive Neuromodulation Device Customer

11 Global Non-invasive Neuromodulation Device Market Forecast

11.1 Global Non-invasive Neuromodulation Device Forecast by Region

11.1.1 Global Non-invasive Neuromodulation Device Forecast by Regions (2021-2026)

11.2.2 Global Non-invasive Neuromodulation Device Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Non-invasive Neuromodulation Device Forecast by Type

11.7 Global Non-invasive Neuromodulation Device Forecast by Application

12 Key Players Analysis

12.1 Neuroelectrics

12.1.1 Neuroelectrics Company Information

12.1.2 Neuroelectrics Non-invasive Neuromodulation Device Product Offered

12.1.3 Neuroelectrics Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Neuroelectrics Main Business Overview

12.1.5 Neuroelectrics Latest Developments

12.2 Magstim

12.2.1 Magstim Company Information

12.2.2 Magstim Non-invasive Neuromodulation Device Product Offered

12.2.3 Magstim Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Magstim Main Business Overview

12.2.5 Magstim Latest Developments

12.3 NeuroCare Group

12.3.1 NeuroCare Group Company Information

12.3.2 NeuroCare Group Non-invasive Neuromodulation Device Product Offered

12.3.3 NeuroCare Group Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 NeuroCare Group Main Business Overview

12.3.5 NeuroCare Group Latest Developments

12.4 Soterix Medical

12.4.1 Soterix Medical Company Information

12.4.2 Soterix Medical Non-invasive Neuromodulation Device Product Offered

12.4.3 Soterix Medical Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Soterix Medical Main Business Overview

12.4.5 Soterix Medical Latest Developments

12.5 Newronika

12.5.1 Newronika Company Information

12.5.2 Newronika Non-invasive Neuromodulation Device Product Offered

12.5.3 Newronika Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Newronika Main Business Overview

12.5.5 Newronika Latest Developments

12.6 Rogue Resolutions

12.6.1 Rogue Resolutions Company Information

12.6.2 Rogue Resolutions Non-invasive Neuromodulation Device Product Offered

12.6.3 Rogue Resolutions Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Rogue Resolutions Main Business Overview

12.6.5 Rogue Resolutions Latest Developments

12.7 Medtronic

12.7.1 Medtronic Company Information

12.7.2 Medtronic Non-invasive Neuromodulation Device Product Offered

12.7.3 Medtronic Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Medtronic Main Business Overview

12.7.5 Medtronic Latest Developments

12.8 Philips Healthcare

12.8.1 Philips Healthcare Company Information

12.8.2 Philips Healthcare Non-invasive Neuromodulation Device Product Offered

12.8.3 Philips Healthcare Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Philips Healthcare Main Business Overview

12.8.5 Philips Healthcare Latest Developments

12.9 Shenzhen Yingchi Technology

12.9.1 Shenzhen Yingchi Technology Company Information

12.9.2 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Product Offered

12.9.3 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Shenzhen Yingchi Technology Main Business Overview

12.9.5 Shenzhen Yingchi Technology Latest Developments

12.10 Shenzhen Hanix United

12.10.1 Shenzhen Hanix United Company Information

12.10.2 Shenzhen Hanix United Non-invasive Neuromodulation Device Product Offered

12.10.3 Shenzhen Hanix United Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Shenzhen Hanix United Main Business Overview

12.10.5 Shenzhen Hanix United Latest Developments

12.11 Shanghai Qiankang Medical Care Company

12.11.1 Shanghai Qiankang Medical Care Company Company Information

12.11.2 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Product Offered

12.11.3 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Shanghai Qiankang Medical Care Company Main Business Overview

12.11.5 Shanghai Qiankang Medical Care Company Latest Developments

12.12 TCT Research

12.12.1 TCT Research Company Information

12.12.2 TCT Research Non-invasive Neuromodulation Device Product Offered

12.12.3 TCT Research Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 TCT Research Main Business Overview

12.12.5 TCT Research Latest Developments

12.13 EB Neuro SpA

12.13.1 EB Neuro SpA Company Information

12.13.2 EB Neuro SpA Non-invasive Neuromodulation Device Product Offered

12.13.3 EB Neuro SpA Non-invasive Neuromodulation Device Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 EB Neuro SpA Main Business Overview

12.13.5 EB Neuro SpA Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Non-invasive Neuromodulation Device Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Transcranial Direct Current Stimulation (tDCS)

Table 3. Major Players of Transcranial Alternating Current Stimulation (tACS)

Table 4. Major Players of Transcranial Pulsed Current Stimulation (tPCS)

Table 5. Major Players of Transcranial Random Noise Stimulation (tRNS)

Table 6. Major Players of Electroconvulsive therapy (ECT)

Table 7. Major Players of Others

Table 8. Global Non-invasive Neuromodulation Device Sales by Type (2016-2021) & (K Units)

Table 9. Global Non-invasive Neuromodulation Device Sales Market Share by Type (2016-2021)

Table 10. Global Non-invasive Neuromodulation Device Revenue by Type (2016-2021) & ($ million)

Table 11. Global Non-invasive Neuromodulation Device Revenue Market Share by Type (2016-2021)

Table 12. Global Non-invasive Neuromodulation Device Sale Price by Type (2016-2021)

Table 13. Global Non-invasive Neuromodulation Device Sales by Application (2016-2021) & (K Units)

Table 14. Global Non-invasive Neuromodulation Device Sales Market Share by Application (2016-2021)

Table 15. Global Non-invasive Neuromodulation Device Value by Application (2016-2021)

Table 16. Global Non-invasive Neuromodulation Device Revenue Market Share by Application (2016-2021)

Table 17. Global Non-invasive Neuromodulation Device Sale Price by Application (2016-2021)

Table 18. Global Non-invasive Neuromodulation Device Sales by Company (2019-2021) & (K Units)

Table 19. Global Non-invasive Neuromodulation Device Sales Market Share by Company (2019-2021)

Table 20. Global Non-invasive Neuromodulation Device Revenue by Company (2019-2021) ($ Millions)

Table 21. Global Non-invasive Neuromodulation Device Revenue Market Share by Company (2019-2021)

Table 22. Global Non-invasive Neuromodulation Device Sale Price by Company (2019-2021)

Table 23. Key Manufacturers Non-invasive Neuromodulation Device Producing Area Distribution and Sales Area

Table 24. Players Non-invasive Neuromodulation Device Products Offered

Table 25. Non-invasive Neuromodulation Device Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Non-invasive Neuromodulation Device Sales by Region (2016-2021) (K Units)

Table 29. Global Non-invasive Neuromodulation Device Sales Market Share by Region (2016-2021)

Table 30. Global Non-invasive Neuromodulation Device Revenue by Region (2016-2021) & ($ Millions)

Table 31. Global Non-invasive Neuromodulation Device Revenue Market Share by Region (2016-2021)

Table 32. Americas Non-invasive Neuromodulation Device Sales by Country (2016-2021) & (K Units)

Table 33. Americas Non-invasive Neuromodulation Device Sales Market Share by Country (2016-2021)

Table 34. Americas Non-invasive Neuromodulation Device Revenue by Country (2016-2021) & ($ Millions)

Table 35. Americas Non-invasive Neuromodulation Device Revenue Market Share by Country (2016-2021)

Table 36. Americas Non-invasive Neuromodulation Device Sales by Type (2016-2021) & (K Units)

Table 37. Americas Non-invasive Neuromodulation Device Sales Market Share by Type (2016-2021)

Table 38. Americas Non-invasive Neuromodulation Device Sales by Application (2016-2021) & (K Units)

Table 39. Americas Non-invasive Neuromodulation Device Sales Market Share by Application (2016-2021)

Table 40. APAC Non-invasive Neuromodulation Device Sales by Region (2016-2021) & (K Units)

Table 41. APAC Non-invasive Neuromodulation Device Sales Market Share by Region (2016-2021)

Table 42. APAC Non-invasive Neuromodulation Device Revenue by Region (2016-2021) & ($ Millions)

Table 43. APAC Non-invasive Neuromodulation Device Revenue Market Share by Region (2016-2021)

Table 44. APAC Non-invasive Neuromodulation Device Sales by Type (2016-2021) & (K Units)

Table 45. APAC Non-invasive Neuromodulation Device Sales Market Share by Type (2016-2021)

Table 46. APAC Non-invasive Neuromodulation Device Sales by Application (2016-2021) & (K Units)

Table 47. APAC Non-invasive Neuromodulation Device Sales Market Share by Application (2016-2021)

Table 48. Europe Non-invasive Neuromodulation Device Sales by Country (2016-2021) & (K Units)

Table 49. Europe Non-invasive Neuromodulation Device Sales Market Share by Country (2016-2021)

Table 50. Europe Non-invasive Neuromodulation Device Revenue by Country (2016-2021) & ($ Millions)

Table 51. Europe Non-invasive Neuromodulation Device Revenue Market Share by Country (2016-2021)

Table 52. Europe Non-invasive Neuromodulation Device Sales by Type (2016-2021) & (K Units)

Table 53. Europe Non-invasive Neuromodulation Device Sales Market Share by Type (2016-2021)

Table 54. Europe Non-invasive Neuromodulation Device Sales by Application (2016-2021) & (K Units)

Table 55. Europe Non-invasive Neuromodulation Device Sales Market Share by Application (2016-2021)

Table 56. Middle East & Africa Non-invasive Neuromodulation Device Sales by Country (2016-2021) & (K Units)

Table 57. Middle East & Africa Non-invasive Neuromodulation Device Sales Market Share by Country (2016-2021)

Table 58. Middle East & Africa Non-invasive Neuromodulation Device Revenue by Country (2016-2021) & ($ Millions)

Table 59. Middle East & Africa Non-invasive Neuromodulation Device Revenue Market Share by Country (2016-2021)

Table 60. Middle East & Africa Non-invasive Neuromodulation Device Sales by Type (2016-2021) & (K Units)

Table 61. Middle East & Africa Non-invasive Neuromodulation Device Sales Market Share by Type (2016-2021)

Table 62. Middle East & Africa Non-invasive Neuromodulation Device Sales by Application (2016-2021) & (K Units)

Table 63. Middle East & Africa Non-invasive Neuromodulation Device Sales Market Share by Application (2016-2021)

Table 64. Key and Potential Regions of Non-invasive Neuromodulation Device

Table 65. Key Application and Potential Industries of Non-invasive Neuromodulation Device

Table 66. Key Challenges of Non-invasive Neuromodulation Device

Table 67. Key Trends of Non-invasive Neuromodulation Device

Table 68. Non-invasive Neuromodulation Device Distributors List

Table 69. Non-invasive Neuromodulation Device Customer List

Table 70. Global Non-invasive Neuromodulation Device Sales Forecast by Region (2021-2026) & (K Units)

Table 71. Global Non-invasive Neuromodulation Device Consumption Market Forecast by Region

Table 72. Global Non-invasive Neuromodulation Device Revenue Forecast by Region (2021-2026) & ($ millions)

Table 73. Global Non-invasive Neuromodulation Device Revenue Market Share Forecast by Region (2021-2026)

Table 74. Americas Non-invasive Neuromodulation Device Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Americas Non-invasive Neuromodulation Device Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. APAC Non-invasive Neuromodulation Device Sales Forecast by Region (2021-2026) & (K Units)

Table 77. APAC Non-invasive Neuromodulation Device Revenue Forecast by Region (2021-2026) & ($ millions)

Table 78. Europe Non-invasive Neuromodulation Device Sales Forecast by Country (2021-2026) & (K Units)

Table 79. Europe Non-invasive Neuromodulation Device Revenue Forecast by Country (2021-2026) & ($ millions)

Table 80. Middle East & Africa Non-invasive Neuromodulation Device Sales Forecast by Country (2021-2026) & (K Units)

Table 81. Middle East & Africa Non-invasive Neuromodulation Device Revenue Forecast by Country (2021-2026) & ($ millions)

Table 82. Global Non-invasive Neuromodulation Device Sales Forecast by Type (2021-2026) & (K Units)

Table 83. Global Non-invasive Neuromodulation Device Sales Market Share Forecast by Type (2021-2026)

Table 84. Global Non-invasive Neuromodulation Device Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 85. Global Non-invasive Neuromodulation Device Revenue Market Share Forecast by Type (2021-2026)

Table 86. Global Non-invasive Neuromodulation Device Sales Forecast by Application (2021-2026) & (K Units)

Table 87. Global Non-invasive Neuromodulation Device Sales Market Share Forecast by Application (2021-2026)

Table 88. Global Non-invasive Neuromodulation Device Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 89. Global Non-invasive Neuromodulation Device Revenue Market Share Forecast by Application (2021-2026)

Table 90. Neuroelectrics Basic Information, Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors

Table 91. Neuroelectrics Non-invasive Neuromodulation Device Product Offered

Table 92. Neuroelectrics Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 93. Neuroelectrics Main Business

Table 94. Neuroelectrics Latest Developments

Table 95. Magstim Basic Information, Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors

Table 96. Magstim Non-invasive Neuromodulation Device Product Offered

Table 97. Magstim Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 98. Magstim Main Business

Table 99. Magstim Latest Developments

Table 100. NeuroCare Group Basic Information, Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors

Table 101. NeuroCare Group Non-invasive Neuromodulation Device Product Offered

Table 102. NeuroCare Group Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 103. NeuroCare Group Main Business

Table 104. NeuroCare Group Latest Developments

Table 105. Soterix Medical Basic Information, Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors

Table 106. Soterix Medical Non-invasive Neuromodulation Device Product Offered

Table 107. Soterix Medical Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 108. Soterix Medical Main Business

Table 109. Soterix Medical Latest Developments

Table 110. Newronika Basic Information, Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors

Table 111. Newronika Non-invasive Neuromodulation Device Product Offered

Table 112. Newronika Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 113. Newronika Main Business

Table 114. Newronika Latest Developments

Table 115. Rogue Resolutions Basic Information, Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors

Table 116. Rogue Resolutions Non-invasive Neuromodulation Device Product Offered

Table 117. Rogue Resolutions Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 118. Rogue Resolutions Main Business

Table 119. Rogue Resolutions Latest Developments

Table 120. Medtronic Basic Information, Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors

Table 121. Medtronic Non-invasive Neuromodulation Device Product Offered

Table 122. Medtronic Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 123. Medtronic Main Business

Table 124. Medtronic Latest Developments

Table 125. Philips Healthcare Basic Information, Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors

Table 126. Philips Healthcare Non-invasive Neuromodulation Device Product Offered

Table 127. Philips Healthcare Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 128. Philips Healthcare Main Business

Table 129. Philips Healthcare Latest Developments

Table 130. Shenzhen Yingchi Technology Basic Information, Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors

Table 131. Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Product Offered

Table 132. Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 133. Shenzhen Yingchi Technology Main Business

Table 134. Shenzhen Yingchi Technology Latest Developments

Table 135. Shenzhen Hanix United Basic Information, Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors

Table 136. Shenzhen Hanix United Non-invasive Neuromodulation Device Product Offered

Table 137. Shenzhen Hanix United Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 138. Shenzhen Hanix United Main Business

Table 139. Shenzhen Hanix United Latest Developments

Table 140. Shanghai Qiankang Medical Care Company Basic Information, Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors

Table 141. Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Product Offered

Table 142. Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 143. Shanghai Qiankang Medical Care Company Main Business

Table 144. Shanghai Qiankang Medical Care Company Latest Developments

Table 145. TCT Research Basic Information, Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors

Table 146. TCT Research Non-invasive Neuromodulation Device Product Offered

Table 147. TCT Research Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 148. TCT Research Main Business

Table 149. TCT Research Latest Developments

Table 150. EB Neuro SpA Basic Information, Non-invasive Neuromodulation Device Manufacturing Base, Sales Area and Its Competitors

Table 151. EB Neuro SpA Non-invasive Neuromodulation Device Product Offered

Table 152. EB Neuro SpA Non-invasive Neuromodulation Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 153. EB Neuro SpA Main Business

Table 154. EB Neuro SpA Latest Developments

List of Figures

Figure 1. Picture of Non-invasive Neuromodulation Device

Figure 2. Non-invasive Neuromodulation Device Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Non-invasive Neuromodulation Device Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Non-invasive Neuromodulation Device Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Non-invasive Neuromodulation Device Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Transcranial Direct Current Stimulation (tDCS)

Figure 10. Product Picture of Transcranial Alternating Current Stimulation (tACS)

Figure 11. Product Picture of Transcranial Pulsed Current Stimulation (tPCS)

Figure 12. Product Picture of Transcranial Random Noise Stimulation (tRNS)

Figure 13. Product Picture of Electroconvulsive therapy (ECT)

Figure 14. Product Picture of Others

Figure 15. Global Non-invasive Neuromodulation Device Sales Market Share by Type in 2020

Figure 16. Global Non-invasive Neuromodulation Device Revenue Market Share by Type (2016-2021)

Figure 17. Non-invasive Neuromodulation Device Consumed in Hospital

Figure 18. Global Non-invasive Neuromodulation Device Market: Hospital (2016-2021) & (K Units)

Figure 19. Non-invasive Neuromodulation Device Consumed in Clinic

Figure 20. Global Non-invasive Neuromodulation Device Market: Clinic (2016-2021) & (K Units)

Figure 21. Non-invasive Neuromodulation Device Consumed in Others

Figure 22. Global Non-invasive Neuromodulation Device Market: Others (2016-2021) & (K Units)

Figure 23. Global Non-invasive Neuromodulation Device Sales Market Share by Application (2016-2021)

Figure 24. Global Non-invasive Neuromodulation Device Revenue Market Share by Application in 2020

Figure 25. Non-invasive Neuromodulation Device Revenue Market by Company in 2020 ($ Million)

Figure 26. Global Non-invasive Neuromodulation Device Revenue Market Share by Company in 2020

Figure 27. Global Non-invasive Neuromodulation Device Sales Market Share by Regions (2016-2021)

Figure 28. Global Non-invasive Neuromodulation Device Revenue Market Share by Region in 2020

Figure 29. Americas Non-invasive Neuromodulation Device Sales 2016-2021 (K Units)

Figure 30. Americas Non-invasive Neuromodulation Device Revenue 2016-2021 ($ Millions)

Figure 31. APAC Non-invasive Neuromodulation Device Sales 2016-2021 (K Units)

Figure 32. APAC Non-invasive Neuromodulation Device Revenue 2016-2021 ($ Millions)

Figure 33. Europe Non-invasive Neuromodulation Device Sales 2016-2021 (K Units)

Figure 34. Europe Non-invasive Neuromodulation Device Revenue 2016-2021 ($ Millions)

Figure 35. Middle East & Africa Non-invasive Neuromodulation Device Sales 2016-2021 (K Units)

Figure 36. Middle East & Africa Non-invasive Neuromodulation Device Revenue 2016-2021 ($ Millions)

Figure 37. Americas Non-invasive Neuromodulation Device Sales Market Share by Country in 2020

Figure 38. Americas Non-invasive Neuromodulation Device Revenue Market Share by Country in 2020

Figure 39. Americas Non-invasive Neuromodulation Device Sales Market Share by Type in 2020

Figure 40. Americas Non-invasive Neuromodulation Device Sales Market Share by Application in 2020

Figure 41. United States Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 42. Canada Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 43. Mexico Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 44. Brazil Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 45. APAC Non-invasive Neuromodulation Device Sales Market Share by Region in 2020

Figure 46. APAC Non-invasive Neuromodulation Device Revenue Market Share by Regions in 2020

Figure 47. APAC Non-invasive Neuromodulation Device Sales Market Share by Type in 2020

Figure 48. APAC Non-invasive Neuromodulation Device Sales Market Share by Application in 2020

Figure 49. China Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 50. Japan Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 51. Korea Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 52. Southeast Asia Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 53. India Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 54. Australia Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 55. Europe Non-invasive Neuromodulation Device Sales Market Share by Country in 2020

Figure 56. Europe Non-invasive Neuromodulation Device Revenue Market Share by Country in 2020

Figure 57. Europe Non-invasive Neuromodulation Device Sales Market Share by Type in 2020

Figure 58. Europe Non-invasive Neuromodulation Device Sales Market Share by Application in 2020

Figure 59. Germany Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 60. France Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 61. UK Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 62. Italy Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 63. Russia Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 64. Middle East & Africa Non-invasive Neuromodulation Device Sales Market Share by Country in 2020

Figure 65. Middle East & Africa Non-invasive Neuromodulation Device Revenue Market Share by Country in 2020

Figure 66. Middle East & Africa Non-invasive Neuromodulation Device Sales Market Share by Type in 2020

Figure 67. Middle East & Africa Non-invasive Neuromodulation Device Sales Market Share by Application in 2020

Figure 68. Egypt Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 69. South Africa Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 70. Israel Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 71. Turkey Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 72. GCC Country Non-invasive Neuromodulation Device Revenue Growth 2016-2021 ($ Millions)

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles